Evidence map›Paper›PMID 37268778›Full record

ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2023

Emerging Adult and Caregiver Psychosocial Experiences with Severe Hypoglycemic Events and the Perceived Impact of Nasal Glucagon: A Cross-Sectional Study.

Caitlin S Kelly, Huyen Nguyen, Weixiu Luo, Katherine Chapman, Jiat-Ling Poon, Magaly Perez-Nieves, Levenia Baker, Wendy A Wolf, Beth Mitchell

Open access · goldAbstract read
In one paragraph

Article in Diabetes therapy : research, treatment and education of diabetes and related disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Caitlin S KellyT1D Exchange, 11 Avenue de Lafayette, 5th Floor, Boston, MA, 02111, USA. ckelly@t1dexchange.org.
Huyen NguyenT1D Exchange, 11 Avenue de Lafayette, 5th Floor, Boston, MA, 02111, USA.
Weixiu LuoTechData Service, King of Prussia, PA, USA.
Katherine ChapmanT1D Exchange, 11 Avenue de Lafayette, 5th Floor, Boston, MA, 02111, USA.
Jiat-Ling PoonEli Lilly and Company, Indianapolis, IN, USA.
Magaly Perez-NievesEli Lilly and Company, Indianapolis, IN, USA.
Levenia BakerEli Lilly and Company, Indianapolis, IN, USA.
Wendy A WolfT1D Exchange, 11 Avenue de Lafayette, 5th Floor, Boston, MA, 02111, USA.
Beth MitchellEli Lilly and Company, Indianapolis, IN, USA.
Eli Lilly (United States) · UST1D Exchange · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSevere hypoglycemic events are distressing. Although past studies have shown that young adulthood is a potentially distressing time, few studies have explored distress about severe hypoglycemia in this age group. The real-world psychosocial experiences of potential severe hypoglycemic events and the perceived impact of glucagon treatments like nasal glucagon are currently unknown. We explored perceptions of severe hypoglycemic events and impact of nasal glucagon on psychosocial experiences with these events in emerging adults with type 1 diabetes and caregivers of emerging adults and children/teens. Further, we compared perceptions of preparedness and protection in handling severe hypoglycemic events with nasal glucagon versus the emergency glucagon kit that requires reconstitution (e-kit).

methodsThis observational, cross-sectional study enrolled emerging adults (aged 18-26; N = 364) with type 1 diabetes, caregivers of emerging adults (aged 18-26; N = 138) with type 1 diabetes, and caregivers of children/teens (aged 4-17; N = 315) with type 1 diabetes. Participants completed an online survey about their experiences with severe hypoglycemia, perceptions of nasal glucagon impact on psychosocial experiences, and perceptions of feeling prepared and protected with nasal glucagon and the e-kit.

resultsMany emerging adults (63.7%) agreed that the experience of severe hypoglycemic events was distressing; 33.3% and 46.7% of caregivers of emerging adults and children/teens, respectively, reported distress. Participants reported positive perceptions of nasal glucagon impact, particularly improved confidence in other people's ability to help during severe hypoglycemic events: emerging adults, 81.4%; caregivers of emerging adults, 77.6%; caregivers of children/teens, 75.5%. Participants demonstrated higher perceptions of preparedness and protection for nasal glucagon than for the e-kit (p < 0.001).

conclusionsParticipants reported improved confidence in other people's ability to help during severe hypoglycemic events since having nasal glucagon available. This suggests that nasal glucagon may help broaden the support network for young people with type 1 diabetes and their caregivers.

Indexed as

CaregiversCross-sectional studiesDiabetes mellitus, type 1HypoglycemiaNasal glucagon

Identifiers

PMID37268778
PMCPMC10299968
OpenAlexW4379197373

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.